Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD34+ Stem Cells”

228 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 228 results

Testing effectiveness (Phase 2)UnknownNCT02709876
What this trial is testing

Autologous Bone Marrow-Derived CD34+, CD133+, and CD271+ Stem Cell Transplantation for Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Stem Cells Arabia 50
Early research (Phase 1)Study completedNCT02193191
What this trial is testing

Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells and Evaluation of Globin Gene Transfer in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Memorial Sloan Kettering Cancer Center 25
Very early researchLooking for participantsNCT06565026
What this trial is testing

CS-206 in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
CorrectSequence Therapeutics Co., Ltd 5
Testing effectiveness (Phase 2)Study completedNCT02500550
What this trial is testing

Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Kiadis Pharma 15
Testing effectiveness (Phase 2)Study completedNCT00074997
What this trial is testing

An Efficacy and Safety Study of Autologous Cluster of Differentiation 34 (CD34+) Hematopoietic Progenitor Cells Transduced With Placebo or an Anti- Human Immunodeficiency Virus Type 1 (HIV-1) Ribozyme (OZ1) in Participants With HIV-1 Infection

Who this might be right for
HIV-1
Janssen-Cilag Pty Ltd 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT00319657
What this trial is testing

Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs

Who this might be right for
Immune Tolerance
Stanford University 15
Testing effectiveness (Phase 2)Looking for participantsNCT03538899
What this trial is testing

Autologous Gene Therapy for Artemis-Deficient SCID

Who this might be right for
Severe Combined Immunodeficiency
University of California, San Francisco 24
Large-scale testing (Phase 3)Study completedNCT02454231
What this trial is testing

Monocentric Trial: Stem Cell Emergency Life Threatening Limbs Arteriopathy (SCELTA)

Who this might be right for
Critical Limb Ischemia
University of Florence 45
Not applicableLooking for participantsNCT07604467
What this trial is testing

The Role of CD34+ Stem Cells in the Pathogenesis of Takotsubo Syndrome

Who this might be right for
Tako Tsubo CardiomyopathyMicrovascular DysfunctionCD34+ Stem Cells+2 more
University Medical Centre Ljubljana 40
Testing effectiveness (Phase 2)Ended earlyNCT00221182
What this trial is testing

Stem Cell Study for Patients With Heart Disease

Who this might be right for
Chest PainChronic Myocardial IschemiaCoronary Artery Disease+2 more
Foundation for Biomedical Research and Innovation 1
Testing effectiveness (Phase 2)Study completedNCT00950521
What this trial is testing

Efficacy Study of CD34 Stem Cell in Chronic Stroke Patients

Who this might be right for
StrokeMiddle Cerebral Artery Infarction
China Medical University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00993486
What this trial is testing

Dose-ranging Study of a Single Administration of T-cell Add-back Depleted of Host Alloreactive Cells in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor

Who this might be right for
Hematologic DiseasesHematologic Malignancies
Kiadis Pharma 19
Not applicableUnknownNCT06287086
What this trial is testing

Clinical Study on the Safety and Efficacy of BRL-101 in the Treatment of Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Bioray Laboratories 1
Early research (Phase 1)Ended earlyNCT02370888
What this trial is testing

Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual Disease

Who this might be right for
Leukemia, MyeloidMyelodysplastic Syndromes
University of Florida 11
Testing effectiveness (Phase 2)Looking for participantsNCT05961410
What this trial is testing

Eltrombopag for Peripheral Blood Stem Cell Harvest

Who this might be right for
LymphomaPeripheral Blood Stem Cell Transplantation
National Taiwan University Hospital 46
Testing effectiveness (Phase 2)Study completedNCT01734850
What this trial is testing

Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection

Who this might be right for
Human Immunodeficiency Virus
Calimmune, Inc. 13
Not applicableStudy completedNCT06678152
What this trial is testing

Nicotine's Effect on Cancer Stem Cell Markers in Human Umbilical Cord Tissue

Who this might be right for
Umbilical Cord IssueNicotine AddictionPregnancy Related+1 more
Celal Bayar University 70
Early research (Phase 1)Looking for participantsNCT06414889
What this trial is testing

Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder

Who this might be right for
RUNX1 Familial Platelet Disorder
M.D. Anderson Cancer Center 4
Early research (Phase 1)Ended earlyNCT04925206
What this trial is testing

A Safety and Efficacy Study Evaluating ET-01 in Subjects with Transfusion Dependent Β-Thalassaemia

Who this might be right for
Transfusion Dependent Beta-Thalassaemia
EdiGene (GuangZhou) Inc. 8
Not applicableLooking for participantsNCT00001405
What this trial is testing

Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes

Who this might be right for
GranulomaGranulomatous Disease, ChronicLeukocyte Disease+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 850
Load More Results